EQT exits Galderma Group AG in full via largest sponsor-backed block trade ever

EQT Sweden

EQT completes final sell-down in Galderma, a global dermatology company delivering science-backed solutions to healthcare professionals, consumers and patients worldwideUnder EQT's ownership, Galderma significantly accelerated revenue growth, increased investment in research and development, and built one of the broadest portfolios of clinically-proven flagship brands in dermatology. Galderma completed one of the largest IPOs in Europe in 2024, and its share price has nearly tripled since the IPOThe sale resulted in aggregate gross proceeds of c. CHF 4.9 billion, of which EQT VIII received c. CHF 1.3 billion. It is the largest sponsor-backed block trade in historyIn total, EQT has realized c. CHF 21 billion / USD 26 billion of proceeds for its funds and co-investors through the sale of Galderma shares, representing the largest value-creation outcome in EQT's historyView original content:https://www.prnewswire.co.uk/news-releases/eqt-exits-galderma-group-ag-in-full-via-largest-sponsor-backed-block-trade-ever-302713652.html